openPR Logo
Press release

PFAS Testing Market worth $217 million by 2028

05-21-2024 09:26 PM CET | Health & Medicine

Press release from: ABNewswire

Agilent Technologies, Inc. plans to invest $20 million to expand its Shanghai manufacturing center to meet growing demand in China for the company's advanced liquid chromatography (LC), spectrometer, and mass spectroscopy (MS) systems.

Agilent Technologies, Inc. plans to invest $20 million to expand its Shanghai manufacturing center to meet growing demand in China for the company's advanced liquid chromatography (LC), spectrometer, and mass spectroscopy (MS) systems.

PFAS Testing market in terms of revenue was estimated to be worth $63 million in 2023 and is poised to reach $121 million by 2028, growing at a CAGR of 14.0% from 2023 to 2028 according to a latest report published by MarketsandMarkets Trademark .
PFAS Testing Market [https://www.marketsandmarkets.com/Market-Reports/pfas-testing-market-168277170.html?utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $63 million in 2023 and is poised to reach $121 million by 2028, growing at a CAGR of 14.0% from 2023 to 2028 according to a new report by MarketsandMarkets. Factors such as increasing funding for wastewater treatment projects/programs and increasing efforts to raise awareness for PFAS testing for environmental protection are high growth prospects for the PFAS testing market during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=168277170 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=168277170&utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral]

The LC-MS-MS segment is to register a significant growth rate over the forecast period of 2023-2028.

Based on the technique, over the forecast period of 2023-2028, the LC-MS-MS segment is to register a significant growth rate. The key factor encouraging the growth of this segment during the forecast period is the broad applicability of LC-MS-MS for testing of various applications such as environmental, food, and biofluids testing, rising number of contract testing labs using LC-MS-MS coupled with higher outsourcing from govt and industrial facilities for wastewater and potable water.

The drinking water standards segment accounted for the largest share of PFAS testing in 2023-2028.

Based on application, the drinking water segment is estimated to hold the largest market share of the PFAS testing market during the forecast period. Increased regulations and legislations set forth by government organizations have triggered the drinking water testing, inspection, and certification of water samples by governments and manufacturing companies lead to a large share of this segment.

Asia Pacific registered the highest CAGR in the market during the forecast period.

In 2023, Asia Pacific is expected to register the highest CAGR in the market for PFAS testing during the forecast period. Asia Pacific comprises China, India, South Korea, Taiwan, and Singapore, and the rest of Asia Pacific. Factors such as the increasing government emphasis on the strict implementation of pollution control strategies, rapid and large-scale industrialization, increasingly stringent environmental regulation policies, and the growing need to comply with safety regulations are driving the growth of the APAC PFAS testing market during the forecast period.

Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=168277170 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=168277170&utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral]

PFAS Testing Market Dynamics:

Drivers:

1. Greater regulatory emphasis on effective pollution monitoring and control

Restraints:

1. Stringent storage requirements for PFAS testing reagents and analytical standards

Opportunities:

1. Regulatory agencies to control environmental pollution due to PFAS contamination

Challenge:

1. Inadequate supporting infrastructure and the shortage of skilled professionals

Key Market Players of PFAS Testing Industry:

As of 2022, prominent players in PFAS testing are Merck KGaA (Germany), Agilent Technologies (US), LGC Limited (UK), Waters Corporation (US), Biotage (Sweden), AccuStandard, Inc. (US), PerkinElmer, Inc. (US), Thermo Fisher Scientific, Inc. (US), Phenomenex (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and Shimadzu Corporation (Japan), among others.

A breakdown of the primary participants referred to for this report is provided below:

* By Company Type: Tier 1-25%, Tier 2-30%, and Tier 3- 45%
* By Designation: Director-level-30%, C-level-23%, and Others-47%
* By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America- 6%, MEA- 2%

Get 10% Free Customization on this Report:https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=168277170 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=168277170&utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pfas-testing-market-worth-217-million-by-2028]
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/pfas-testing-market-168277170.html



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PFAS Testing Market worth $217 million by 2028 here

News-ID: 3506793 • Views:

More Releases from ABNewswire

Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeu
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polycythemia Vera pipeline constitutes 8+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Myelofibrosis Companies in the market include - Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others. DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology as well as the Myelofibrosis market trends in the United States, EU4 (Germany, Spain,
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentec
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Obser …
The Key Asthma Companies in the market inlcude - GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharmaceuticals, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Regeneron Pharmaceuticals, RAPT Therapeutics, Inc., Incyte Corporation, Areteia Therapeutics, Suzhou Connect Biopharmaceuticals, Ltd., Cumberland Pharmaceuticals, Pulmatrix Inc., and others. DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Asthma, historical and
Inflammatory Bowel Disease Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly and Company, Gilead
Inflammatory Bowel Disease Market Positioned for Accelerated Development Through …
The Key Inflammatory Bowel Disease Companies: AbbVie, Janssen Pharmaceuticals, Abivax, Morphic Therapeutic, CJ Bioscience/4D Pharma, RedHill Biopharma, Tryp Therapeutics, Eli Lilly and Company, Gilead, Galapagos, Applied Molecular Transport, Protagonist Therapeutics, Janssen, AstraZeneca, Vifor Pharma, Astellas Pharma, Shield Therapeutics, Takeda, Ocera Therapeutics, Sanofi, Morphic Therapeutic, Inc., Bausch Health Americas, Inc., Qu Biologics Inc., Vifor Pharma, and others DelveInsight's "Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding

All 5 Releases


More Releases for PFAS

Global PFAS-free Membranes Market Outlook Report 2025
Global Info Research's report is a detailed and comprehensive analysis for global PFAS-free Membranes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the PFAS-free Membranes market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of
PFAS-free Polymer Membranes Market Demand Analysis Report 2025
Global Info Research announces the release of the report "Global PFAS-free Polymer Membranes Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the PFAS-free Polymer Membranes market scenario, including a thorough analysis of the PFAS-free Polymer Membranes market size, sales quantity, average price, revenue, gross margin and market share.The PFAS-free Polymer Membranes report provides an in-depth analysis of the competitive landscape,
PFAS Filtration Market: Advanced Solutions for Persistent Contaminants
𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐑𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟑.𝟖𝟓 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑 𝐀𝐦𝐢𝐝𝐬𝐭 𝐑𝐢𝐬𝐢𝐧𝐠 𝐏𝐅𝐀𝐒 𝐂𝐨𝐧𝐜𝐞𝐫𝐧𝐬 𝐚𝐧𝐝 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐏𝐫𝐞𝐬𝐬𝐮𝐫𝐞𝐬 The PFAS filtration market is experiencing substantial expansion, driven by escalating concerns over per- and polyfluoroalkyl substances (PFAS) contamination in drinking water, industrial effluents, and consumer goods. Valued at USD 2,089.50 million in 2024, the market is projected to grow at a CAGR of 7.20%, reaching USD 3,855.56 million by 2033. This growth is fueled
PFAS-free Polymer Processing Aids (PFAS-Free PPA Additives), a solution to the p …
In the plastic processing industry, die build-up is a common problem that can lead to surface defects in products, affecting product quality and production efficiency. Die build-up refers to the accumulation of material at the outlet of the mold during plastic processing, forming deposits that are difficult to remove. This phenomenon usually occurs in injection molding, extrusion and other processes, especially in the processing of high viscosity and high melting point
PFAS: What they are & how to avoid them
These "Forever Chemicals" have existed for what seems like forever, but they've just recently begun making headlines. Here's what you need to know about these troubling compounds. In the world we live in today, the alphabet soup of acronyms for both good and bad substances can make your brain feel like mush. But there's one that you've probably seen popping up more and more. And it's one worth remembering. PFAS, or "Forever
Scanunit helps ferry Aurora in first PFAS/PFOS conversion
Battery-powered Öresundslinjen ferry notches up an environmental first with turnkey conversion and decontamination of soon to be outlawed PFAS/PFOS fire-fighting foam to an environmentally friendly alternative. Helsingborg, Sweden February 5: Maritime engineering specialist Scanunit has carried out what it believes is the world's first replacement and decontamination of a PFAS/PFOS1 foam firefighting system on a commercial vessel. Aurora, a 1992-built ferry operated by EQT-owned Öresundslinjen (a subsidiary of Molslinjen), was